The Galleri multi-cancer early detection (MCED) test – which looks for around 50 different types – achieved a seven-fold ...

The results – presented at the ESMO cancer congress and simultaneously published in Annals of Oncology – come after seven ...

EVERSANA to provide integrated commercialization services, enhancing launch readiness and market entry for differentiated ...

On Friday 17th October, the European Society for Medical Oncology’s Annual Meeting 2025 kicked off, with the opening press ...

The FDA has named the first products to take advantage of its recently announced Commissioner's national priority voucher ...

Millions of women worldwide live with endometriosis, which causes symptoms like pain and extreme tiredness and, if untreated, ...

The filing of the legal action comes just a few days after J&J suffered a major setback in its defence in the US against ...

Moreover, innovations in LNP formulations have improved not only their targeting ability, but also their drug-loading ...

Merck KGaA has become the third pharma company to reach an agreement with the Trump administration to cut the cost of some of ...

While the M&A emphasis is currently on life sciences, a business unit which sells products used in R&D and manufacturing ...

Lila Sciences' already impressive $235 million first round financing has continued to build and has now closed at $350 ...

Kailera Therapeutics has raised an eye-watering $600 million in Series B financing to take its lead drug for weight loss into ...